Showing results (51-60 of 387) with videos related to
Sort By:
Pageof 39
RNA (New York, N.Y.)|August 22, 2006
Oscillating kissing stem-loop interactions mediate 5' scanning-dependent translation by a viral 3'-cap-independent translation elementAurélie M Rakotondrafara, Charlotta Polacek, Eva Harris, et al.Plos Neglected Tropical Diseases|March 27, 2012
Dominant cross-reactive B cell response during secondary acute dengue virus infection in humansSimona Zompi, Magelda Montoya, Marie O Pohl, et al.BMJ Supportive & Palliative Care|March 29, 2020
Confidence and skills for cystic fibrosis end-of-life careEva Harris-Skillman, Stephen Chapman, Aoife Lowney, et al.Annual Review of Virology|July 26, 2018
The Good, the Bad, and the Shocking: The Multiple Roles of Dengue Virus Nonstructural Protein 1 in Protection and PathogenesisDustin R Glasner, Henry Puerta-Guardo, P Robert Beatty, et al.Current Opinion in Virology|November 25, 2017
Zika virus infection of first-trimester human placentas: utility of an explant model of replication to evaluate correlates of immune protection ex vivoMatthew Petitt, Takako Tabata, Henry Puerta-Guardo, et al.Novartis Foundation Symposium|February 27, 2007
Molecular biology of flavivirusesEva Harris, Katherine L Holden, Dianna Edgil, et al.Proceedings of the National Academy of Sciences of the United States of America|January 6, 2016
Neutralizing antibody titers against dengue virus correlate with protection from symptomatic infection in a longitudinal cohortLeah C Katzelnick, Magelda Montoya, Lionel Gresh, et al.Bio-Protocol|September 22, 2017
Preparation of Mosquito Salivary Gland Extract and Intradermal Inoculation of MiceMichael A Schmid, Elizabeth Kauffman, Anne Payne, et al.Mbio|March 13, 2026
The contribution of viral toxins to infection and pathogenesisScott B Biering, Henry Puerta-Guardo, Felix Pahmeier, et al.BMC Public Health|July 13, 2017
Camino Verde (The Green Way): evidence-based community mobilisation for dengue control in Nicaragua and Mexico: feasibility study and study protocol for a randomised controlled trialNeil Andersson, Jorge Arostegui, Elizabeth Nava-Aguilera, et al.Pageof 39